Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven Grant

Showing results (71-80 of 386) with videos related to

Pageof 39
Sort By:
Texas Heart Institute Journal|May 14, 2009
Endovascular repair of injury to a persistent sciatic arteryFritz J Baumgartner, Anthony Kalinowski, Steven Grant
Cancer Treatment and Research|December 17, 2002
The role of signal transduction pathways in drug and radiation resistanceSteven Grant, Paul B Fisher, Paul Dent
Molecular Cancer Therapeutics|January 7, 2005
The small-molecule Bcl-2 inhibitor HA14-1 interacts synergistically with flavopiridol to induce mitochondrial injury and apoptosis in human myeloma cells through a free radical-dependent and Jun NH2-terminal kinase-dependent mechanismXin-Yan Pei, Yun Dai, Steven Grant
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2004
Synergistic induction of oxidative injury and apoptosis in human multiple myeloma cells by the proteasome inhibitor bortezomib and histone deacetylase inhibitorsXin-Yan Pei, Yun Dai, Steven Grant
Molecular Pharmacology|October 13, 2005
Flavopiridol and histone deacetylase inhibitors promote mitochondrial injury and cell death in human leukemia cells that overexpress Bcl-2Girija Dasmahapatra, Jorge A Almenara, Steven Grant
Expert Opinion on Investigational Drugs|May 8, 2013
Cyclin-dependent kinase inhibitor therapy for hematologic malignanciesPrithviraj Bose, Gary L Simmons, Steven Grant
Blood|January 11, 2003
Induction of tumor necrosis factor by bryostatin 1 is involved in synergistic interactions with paclitaxel in human myeloid leukemia cellsShujie Wang, Zhiliang Wang, Paul Dent, et al.
Cancer Treatment Reviews|January 9, 2010
Exploiting cellular pathways to develop new treatment strategies for AMLAmir T Fathi, Steven Grant, Judith E Karp
Emergency Medicine Australasia : EMA|March 4, 2009
How would Australian hospital staff react to an avian influenza admission, or an influenza pandemic?Franco Martinese, Gerben Keijzers, Steven Grant, et al.
Blood Reviews|August 21, 2022
Mechanisms of myeloid leukemogenesis: Current perspectives and therapeutic objectivesIan M Bouligny, Keri R Maher, Steven Grant
Pageof 39

Showing results (71-80 of 386) with videos related to

Sort By:
Pageof 39
Texas Heart Institute Journal|May 14, 2009
Endovascular repair of injury to a persistent sciatic arteryFritz J Baumgartner, Anthony Kalinowski, Steven Grant
Cancer Treatment and Research|December 17, 2002
The role of signal transduction pathways in drug and radiation resistanceSteven Grant, Paul B Fisher, Paul Dent
Molecular Cancer Therapeutics|January 7, 2005
The small-molecule Bcl-2 inhibitor HA14-1 interacts synergistically with flavopiridol to induce mitochondrial injury and apoptosis in human myeloma cells through a free radical-dependent and Jun NH2-terminal kinase-dependent mechanismXin-Yan Pei, Yun Dai, Steven Grant
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2004
Synergistic induction of oxidative injury and apoptosis in human multiple myeloma cells by the proteasome inhibitor bortezomib and histone deacetylase inhibitorsXin-Yan Pei, Yun Dai, Steven Grant
Molecular Pharmacology|October 13, 2005
Flavopiridol and histone deacetylase inhibitors promote mitochondrial injury and cell death in human leukemia cells that overexpress Bcl-2Girija Dasmahapatra, Jorge A Almenara, Steven Grant
Expert Opinion on Investigational Drugs|May 8, 2013
Cyclin-dependent kinase inhibitor therapy for hematologic malignanciesPrithviraj Bose, Gary L Simmons, Steven Grant
Blood|January 11, 2003
Induction of tumor necrosis factor by bryostatin 1 is involved in synergistic interactions with paclitaxel in human myeloid leukemia cellsShujie Wang, Zhiliang Wang, Paul Dent, et al.
Cancer Treatment Reviews|January 9, 2010
Exploiting cellular pathways to develop new treatment strategies for AMLAmir T Fathi, Steven Grant, Judith E Karp
Emergency Medicine Australasia : EMA|March 4, 2009
How would Australian hospital staff react to an avian influenza admission, or an influenza pandemic?Franco Martinese, Gerben Keijzers, Steven Grant, et al.
Blood Reviews|August 21, 2022
Mechanisms of myeloid leukemogenesis: Current perspectives and therapeutic objectivesIan M Bouligny, Keri R Maher, Steven Grant
Pageof 39